These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6125095)

  • 21. Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs.
    Louis WJ; Taylor H; McNeil JJ; Jarrott B; Rand MJ
    Am Heart J; 1982 Aug; 104(2 Pt 2):407-12. PubMed ID: 6125097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The new beta-adrenergic antagonists.
    Chung DC; Laschuk MJ
    Can Anaesth Soc J; 1984 Jul; 31(4):430-3. PubMed ID: 6146393
    [No Abstract]   [Full Text] [Related]  

  • 23. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of beta-adrenoceptor blocking properties of sotalol, oxprenolol, propranolol and pindolol on rabbit intestinal smooth muscle.
    Salimi M
    Pharmacology; 1975; 13(5):441-7. PubMed ID: 1802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Beta blockers in migraine prophylaxis].
    Shimizu T
    Brain Nerve; 2009 Oct; 61(10):1125-30. PubMed ID: 19882938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Class III action of beta-blocking agents.
    Taggart P; Donaldson R; Abed J; Nashat F
    Cardiovasc Res; 1984 Nov; 18(11):683-9. PubMed ID: 6149809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
    Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
    Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.
    Boucher M; Duchêne-Marullaz P; Moundanga JL
    Br J Pharmacol; 1986 Sep; 89(1):119-27. PubMed ID: 2879587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H; Kristek J; Heuer H; Bender F
    Arzneimittelforschung; 1981; 31(9):1416-22. PubMed ID: 6118162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic variability of beta-adrenergic blocking agents used in cardiology.
    Ågesen FN; Weeke PE; Tfelt-Hansen P; Tfelt-Hansen J;
    Pharmacol Res Perspect; 2019 Aug; 7(4):e00496. PubMed ID: 31338197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic and hormonal adaptations to beta-adrenoceptor blockade. A 24-hour study of acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in 't Veld AJ; van Eck HJ; Boomsma F; Schalekamp MA
    Circulation; 1988 Oct; 78(4):957-68. PubMed ID: 3048776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
    Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
    Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal delivery of beta-blockers.
    Aqil M; Sultana Y; Ali A
    Expert Opin Drug Deliv; 2006 May; 3(3):405-18. PubMed ID: 16640500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
    Fanchamps A
    Am Heart J; 1982 Aug; 104(2 Pt 2):388-406. PubMed ID: 6125096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs.
    Kantelip JP; Duchene-Marullaz P; Delaigue-Fabry R; Eschalier A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):159S-166S. PubMed ID: 6125165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic and beta-adrenergic receptor adaptations during long-term beta-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients.
    van den Meiracker AH; Man in't Veld AJ; Boomsma F; Fischberg DJ; Molinoff PB; Schalekamp MA
    Circulation; 1989 Oct; 80(4):903-14. PubMed ID: 2571431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic differences between beta blockers.
    Wood AJ
    Am Heart J; 1984 Oct; 108(4 Pt 2):1070-7. PubMed ID: 6148865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs.
    Patel BR; Kirschbaum JJ; Poet RB
    J Pharm Sci; 1981 Mar; 70(3):336-8. PubMed ID: 6115047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.